Anne Letsch

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS

Ulrich Keilholz, Anne Letsch, Antonia Busse et al. · Blood · 2009 · 299 citations · Full text

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

Carmen Scheibenbogen, Anne Letsch, Eckhard Thiel et al. · Blood · 2002 · 250 citations

Gender medicine and oncology: report and consensus of an ESMO workshop

Dorothea Wagner, Sabine Oertelt‐Prigione, Alex A. Adjei et al. · Annals of Oncology · 2019 · 203 citations · Full text

Gender Medicine, Gender Identity, Cancer Literacy +14

Natural T cell immunity against cancer.

Dirk Nagorsen, Carmen Scheibenbogen, Francesco M. Marincola et al. · PubMed · 2003 · 196 citations

Tumor Immunology, Cancer Immunosurveillance, T Cell Responses +15

Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer.

Dirk Nagorsen, Ulrich Keilholz, Licia Rivoltini et al. · PubMed · 2000 · 137 citations

Healthy Subjects, Mhc Class, T-regulatory Cell +17